Amplification of Wild-Type RET Represents a Novel Molecular Subtype of Several Cancer Types With Clinical Response to Selpercatinib.
Gandhi MM, Ricciuti B, Harada G, Repetto M, Gildenberg MS, Singh A, Li YY, Gagné A, Wang X, Aizer A, Fitzgerald K, Nishino M, Alessi J, Pecci F, Di Federico A, Fisch A, Drilon A, Nardi V, Sholl L, Awad MM, Rotow J.
Gandhi MM, et al. Among authors: gildenberg ms.
JCO Precis Oncol. 2023 Sep;7:e2300295. doi: 10.1200/PO.23.00295.
JCO Precis Oncol. 2023.
PMID: 37972337
Free PMC article.